News
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.
In Apple’s second-quarter earnings call with investors, CEO Tim Cook highlighted three hospitals that were using the Apple Watch: Nebraska Medicine, Ochsner Health System, and London-based King’s College Hospital.
China-based Sleepace, which has developed a sleep tracking device, raised $7 million in a round led by retail chain Luolai Home Textile with participation from ecommerce giant JD.
The regulatory battles for telemedicine continue to play out slowly in state legislatures across the country.
New York City-based 1DocWay has raised $1.
Forty-one percent of consumers have never heard of telemedicine, according to a new survey of 1,200 consumers conducted by Survey Sampling International on behalf of HealthMine.
Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, outside of a lab setting.
San Francisco-based Limelight Health, which has developed a white-labeled health insurance quoting app, announced that it raised $3 million from MassMutual Ventures, the corporate venture capital arm of Massachusetts Mutual Life Insurance Company (MassMutual), and AXA Strategic Ventures.